Stock Information
Vertex Pharmaceuticals Inc (VRTX)
Ticker Symbol: VRTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $111,308.99 mil
Piotroski score: 5
PE Ratio: 27.1983
EPS (TTM): 15.3331
Revenue (TTM): $46.84 M
Dividend Yield: N/A%
ROE: 22.7%
Latest News
-
Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying?
Sat, May 2, 2026 7:50 AM
-
Canaccord Genuity Maintains Hold on Vertex Pharmaceuticals, Lowers Price Target to $437
Thu, Apr 30, 2026 7:16 PM
-
Eli Lilly is firing on all cylinders, says BMO's Evan Seigerman
Thu, Apr 30, 2026 3:05 PM
-
Vortex Energy Announces Intent to Advance Next Phase of Technical Work at the Robinsons River Salt Project and Engages Lonquist
Thu, Apr 30, 2026 12:00 PM
-
Why CRISPR Therapeutics (CRSP) Is Down 10.1% After Casgevy’s Strong Early Launch Metrics And Earnings Hopes
Wed, Apr 29, 2026 11:06 PM
-
IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight
Wed, Apr 29, 2026 5:00 PM
-
Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth Stock with Promising Technical Setup
Wed, Apr 29, 2026 9:50 AM
-
3 Market-Beating Stocks to Consider Right Now
Wed, Apr 29, 2026 12:44 AM
-
Vertex Gears Up to Report Q1 Earnings: What Investors Can Expect
Tue, Apr 28, 2026 4:34 PM
-
Analysts Estimate Myriad Genetics (MYGN) to Report a Decline in Earnings: What to Look Out for
Tue, Apr 28, 2026 2:00 PM
Key Financials
Financial data not available
